Dianthus Therapeutics Banner

Event Details

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

Goldman Sachs 47th Annual Global Healthcare Conference

Jun 9, 2026 2:40 PM EDT